MTE & Satellite Symposium Sessions

(Please note this programme is subject to change)

Day 1- Friday, 20 October

10:10 AM - 10:50 AM (BST)
Scientific Session - Meet the Experts
Iron Deficiency & IV Iron – The 2023 ESC HF Guidelines and Recent Trial Results: Interpretation & Implementation

  • Welcome and introduction - Patricia Campbell 
  • Review of ESC 2023 guideline update on IV iron - Paul Kalra  
  • Heart-FID and 2023 meta-analysis - Robert John Mentz  
  • Panel discussion 


Supported by an unrestricted educational grant from Pharmacosmos


12:10 PM - 1:00 PM (BST)
Special Live Interactive Session
Management of ATTR-CM

  • Welcome and introduction - Brett Sperry 
  • Understanding ATTR amyloidosis and its burden - Arnt Kristen 
  • Diagnosis state of the art approaches - Fabian Knebel 
  • Management of ATTR-CM: the present and future - Ahmad Masri 
  • Panel discussion 


1:10 PM - 1:50 PM (BST)
Meet the Expert
Best practices in the management of patients with cardiac amyloidosis

  • Welcome and introduction - Peter Van De Meer 
  • Early identification / diagnosis in practice - Daniela Tomasoni 
  • Management of ATTR-CM: best practices - Marianna Fontana 
  • Panel discussion 


Supported by an unrestricted educational grant from AstraZeneca


3:10 PM - 3:50 PM (BST)
Meet the Expert
Management of patients with HFpEF: What did we learn from our HFrEF patients

  • Welcome and introduction - Giuseppe Rosano
  • Barriers for implementation - Clara Ines Saldarriaga 
  • Learnings from HFrEF for HFpEF - Gianluigi Savarese 
  • Panel discussion 


Supported by an unrestricted educational grant from AstraZeneca


5:10 PM - 6:00 PM (BST)
Special Live Interactive Session
Best practices for hyperkalemia management across the cardiorenal spectrum

  • Welcome and introduction - Giuseppe Rosano 
  • The international Delphi consensus on hyperkalemia - Gianluigi Savarese 
  • Practical tools for Raasi optimisation - Ileana Piña 
  • Panel discussion 


9:00 PM - 10:00 PM (BST)
Scientific Session - Meet the Experts
Iron Deficiency & IV Iron – The 2023 ESC HF Guidelines and Recent Trial Results: Interpretation & Implementation

  • Welcome and introduction - Patricia Campbell 
  • Review of ESC 2023 guideline update on IV iron - Paul Kalra  
  • Heart-FID and 2023 meta-analysis - Robert John Mentz  
  • Panel discussion 


Supported by an unrestricted educational grant from Pharmacosmos



Time Zone: (UTC+01:00) London, Edinburgh [Change Time Zone]

Day 2 - Saturday, 21 October

8:20 AM - 8:50 AM (BST)
Meet the Expert
Iron deficiency and heart failure – what we have learnt so far?

  • Welcome and introduction - Ovidiu Chioncel 
  • Clinical impact and treatment of iron deficiency in heart failure - Piotr Ponikowski
  • Management of iron deficiency in heart failure - guidelines and practical considerations - Andrew Sindone 
  • Panel discussion 


Supported by an unrestricted educational grant from CSL Vifor


10:10 AM - 10:50 AM (BST)
Meet the Expert
Practical approaches in the management of hyperkalemia

  • Welcome and introduction: hyperkalemia in the setting of HF - Shelley Zieroth 
  • Practical approaches to hyperkalemia management: the example of the Princess of Wales Hospital - Aaron Wong 
  • Panel discussion 


Supported by an unrestricted educational grant from AstraZeneca


3:10 PM - 3:50 PM (BST)
Meet the Expert
What happens if you fix FMR , but ignore the root cause of heart failure?

  • Welcome and introduction: Stefan Anker 
  • The EMPOWER Trial: providing the clarity needed in the TMVr space: Javed Butler 
  • Carillon: a simple, low risk intervention with dual benefits: Klaus Witte 
  • Round table 


Supported by an unrestricted educational grant from Cardiac Dimensions


8:00 PM - 9:00 PM (BST)
Meet the Expert
Management of patients with HFpEF: What did we learn from our HFrEF patients

  • Welcome and introduction - Giuseppe Rosano
  • Barriers for implementation - Clara Ines Saldarriaga 
  • Learnings from HFrEF for HFpEF - Gianluigi Savarese 
  • Panel discussion 


Supported by an unrestricted educational grant from AstraZeneca



Time Zone: (UTC+01:00) London, Edinburgh [Change Time Zone]

If you’re interested in becoming an educational partner or sponsor at this event, please contact sales@radcliffe-group.com

Sponsors

Gold:

Bronze:

About Translational Medicine Academy

Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.

Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.

For more information on TMA, please visit www.tmacademy.org.

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com